Association between the FABP2 Ala54Thr and CRP+1059C/G polymorphisms and small dense LDL level in patients with atherosclerosis: a case–control study

References

• Ai, M., et al., 2010. Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. Clinical chemistry, 56 (6), 967–976.
   PubMed Web of Science ®Google Scholar
• Albert, M.A., Glynn, R.J., and Ridker, P.M., 2003. Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation, 108 (2), 161–165.
   PubMed Web of Science ®Google Scholar
• Alharbi, K.K., et al., 2014. A54T polymorphism in the fatty acid binding protein 2 studies in a Saudi population with type 2 diabetes mellitus. Lipids in health and disease, 13 (1), 61.
   PubMedGoogle Scholar
• Anand, S.S., et al., 2004. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arteriosclerosis, thrombosis, and vascular biology, 24 (8), 1509–1515.
   PubMed Web of Science ®Google Scholar
• Aulchenko, Y.S., et al., 2009. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nature genetics, 41, 47.
   PubMed Web of Science ®Google Scholar
• Baier, L.J., et al., 1995. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. Journal of clinical investigation, 95 (3), 1281–1287.
   PubMed Web of Science ®Google Scholar
• Besnard, P., et al., 1996. Cellular and molecular aspects of fat metabolism in the small intestine. Proceedings of the nutrition society, 55 (1B), 19–37.
   PubMed Web of Science ®Google Scholar
• Cao, H., and Hegele, R.A., 2000. Human C-reactive protein (CRP) 1059G/C polymorphism. Journal of human genetics, 45 (2), 100–101.
   PubMed Web of Science ®Google Scholar
• Cheraghi, M., et al., 2017. Paraoxonase 1 activity, lipid profile, and atherogenic indexes status in coronary heart disease. Reports of biochemistry & molecular biology, 6 (1), 1–7.
   PubMed Web of Science ®Google Scholar
• Dai, D.-F., et al., 2007. Human C-reactive protein (CRP) gene 1059 G>C polymorphism is associated with plasma CRP concentration in patients receiving coronary angiography. Journal of the formosan medical association, 106 (5), 347–354.
   PubMed Web of Science ®Google Scholar
• De Luis, D., et al., 2008. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on weight loss and insulin levels secondary to two hypocaloric diets: a randomized clinical trial. Diabetes research and clinical practice, 82 (1), 113–118.
   PubMed Web of Science ®Google Scholar
• De Luis, D., et al., 2009. Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients. Obesity surgery, 19 (12), 1691–1696.
   PubMed Web of Science ®Google Scholar
• Duran, G.G., et al., 2016. The relationship between acute coronary artery diseases with c-reactive protein+ 1059 G/C and angiotensin-converting enzyme I/D gene polymorphisms. International journal of clinical and experimental medicine, 9, 20126–20136.
   Web of Science ®Google Scholar
• Fearon, I.M., 2014. Risk factors, oxidative stress, and cardiovascular disease. In: I. Laher, ed. Systems biology of free radicals and antioxidants. Berlin-Heidelberg: Springer, 765–790.
   Google Scholar
• Ghattas, M.H., Abo-Elmatty, D.M., and El-Eraki, A.Z., 2012. C-reactive protein 1059G/C gene polymorphism, C-reactive protein levels and acute myocardial infarction. Journal of cardiovascular medicine (Hagerstown, Md.), 13 (11), 716–719.
   PubMed Web of Science ®Google Scholar
• Hirano, T., et al., 2003. A novel and simple method for quantification of small, dense LDL. Journal of lipid research, 44 (11), 2193–2201.
   PubMed Web of Science ®Google Scholar
• Ivanova, E.A., et al., 2017. 2017. Small dense low-density lipoprotein as biomarker for atherosclerotic diseases. Oxidative medicine and cellular longevity, 2017, 1273042.
   PubMed Web of Science ®Google Scholar
• Jalili, Z., and Onsori, H., 2018. The association of c-reactive protein (CRP) gene polymorphism (+1059 G>C) with type 2 diabetes mellitus in the Northwestern population of Iran. Iranian red crescent medical journal, 20 (11), e65871.
   Google Scholar
• KAUR, R., et al., 2013. C-reactive protein+1059 G>C polymorphism in type 2 diabetes and coronary artery disease patients. Meta Gene, 1, 82–92.
   PubMedGoogle Scholar
• Khattab, S.A., et al., 2017. Intestinal fatty acid binding protein Ala54Thr polymorphism is associated with peripheral atherosclerosis combined with type 2 diabetes mellitus. Journal of diabetes, 9 (9), 821–826.
   PubMed Web of Science ®Google Scholar
• Levy, E., et al., 2001. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. Journal of biological chemistry, 276 (43), 39679–39684.
   PubMed Web of Science ®Google Scholar
• Libby, P., 2012. Inflammation in atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology, 32 (9), 2045–2051.
   PubMed Web of Science ®Google Scholar
• Maeda, S., et al., 2012. Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans. Journal of atherosclerosis and thrombosis, 19 (5), 444–452.
   PubMed Web of Science ®Google Scholar
• Mirbolouk, F., et al., 2019. Frequency of renal artery stenosis and associated factors in patients undergoing coronary angiography. Journal of nephropathology, 8 (2), 14–14.
   Google Scholar
• Nouryazdan, N., et al., 2019. Study of angiotensin-converting enzyme insertion/deletion polymorphism, enzyme activity and oxidized low density lipoprotein in Western Iranians with atherosclerosis: a case-control study. BMC cardiovascular disorders, 19 (1), 184.
   PubMed Web of Science ®Google Scholar
• Paffen, E., and Demaat, M.P., 2006. C-reactive protein in atherosclerosis: a causal factor? Cardiovascular research, 71 (1), 30–39.
   PubMed Web of Science ®Google Scholar
• Pašalić, D., et al., 2009. C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease. Molecular biology reports, 36 (4), 775–780.
   PubMed Web of Science ®Google Scholar
• Payami, B., et al., 2016. Prevalence and predictors of atherosclerotic renal artery stenosis in hypertensive patients undergoing simultaneous coronary and renal artery angiography; a cross-sectional study. Journal of renal injury prevention, 5 (1), 34–38.
   PubMed Web of Science ®Google Scholar
• Perez-Bravo, F., et al., 2006. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism with obesity and insulin resistance in two aboriginal populations from Chile. Acta Diabetologica, 43 (4), 93–98.
   PubMed Web of Science ®Google Scholar
• Raza, S.T., et al., 2017. FTO (rs9939609) genes polymorphism and type 2 diabetes with dyslipidemia. International journal of molecular and cellular medicine, 6, 121.
   PubMed Web of Science ®Google Scholar
• Richieri, G.V., et al., 2000. Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry, 39 (24), 7197–7204.
   PubMed Web of Science ®Google Scholar
• Ridker, P.M., et al., 2002. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England journal of medicine, 347 (20), 1557–1565.
   PubMed Web of Science ®Google Scholar
• Robbins, C.S., et al., 2013. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nature medicine, 19 (9), 1166–1172.
   PubMed Web of Science ®Google Scholar
• Saarinen, L., et al., 1998. Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM. Diabetes care, 21 (5), 849–850.
   PubMed Web of Science ®Google Scholar
• Shahsavari, G., et al., 2017. The effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: a case series study. ARYA atherosclerosis, 13 (6), 282–287.
   PubMed Web of Science ®Google Scholar
• Silva, E.H., et al., 2019. Vascular dysfunction and atherosclerosis in chronic kidney disease; A distinct entity. Journal of nephropathology, 8 (2), 17–17.
   Google Scholar
• Smathers, R.L., and Petersen, D.R., 2011. The human fatty acid-binding protein family: evolutionary divergences and functions. Human genomics, 5 (3), 170–191.
   PubMedGoogle Scholar
• Soltero-Perez, I., 2002. Toward a new definition of atherosclerosis including hypertension: a proposal. Journal of human hypertension, 16, S23.
   PubMed Web of Science ®Google Scholar
• Tavridou, A., et al., 2009. Thr54 allele of fatty-acid binding protein 2 gene is associated with obesity but not type 2 diabetes mellitus in a Caucasian population. Diabetes research and clinical practice, 84 (2), 132–137.
   PubMed Web of Science ®Google Scholar
• Van Nieuwenhoven, F., Van der Vusse, G., and Glatz, J., 1996. Membrane‐associated and cytoplasmic fatty acid‐binding proteins. Lipids, 31 (1), S223–S227.
   PubMedGoogle Scholar
• Wanby, P., et al., 2004. The FABP2 gene polymorphism in cerebrovascular disease. Acta neurologica scandinavica, 110 (6), 355–360.
   PubMed Web of Science ®Google Scholar
• Yalameha, B., 2019a. Antioxidant therapy to improve or resolve atherosclerosis; new hopes and current trends. Journal of nephropharmacology, 8 (2), 18–18.
   Google Scholar
• Yalameha, B., 2019b. Stress oxidative and progression of atherosclerosis. Journal of ischemia and tissue repair, 3, e05.
   Google Scholar
• Yusuf, S., et al., 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The lancet, 364 (9438), 937–952.
   PubMed Web of Science ®Google Scholar